CapsoVision Inc.
CV | NASDAQ
$6.83
-$0.11 (-1.59%)
At close: Oct 30, 2026, 4:00 PM ET
$6.83
$0.00 (0.00%)
Pre-market:
Nov 2, 2026, 4:00 AM ET
Company Profile
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.
Key Executives
| Name | Position |
|---|---|
| Kang Huai Wang | Co-Founder, President, Chief Executive Officer & Director |
| Anna Krylova | Corporate Controller |
| David Garcia | Compliance Officer, SVP of Finance, Principal Financial & Accounting Officer |
| Douglas Atkinson | Senior Vice President of Global Sales |
| Helen Chau | Manager of Human Resources |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 28, 2026 | 8-K | Current Report |
| Sep 23, 2026 | 4 | Filing |
| Sep 23, 2026 | 4/A | [Amend] Filing |
| Sep 23, 2026 | 4/A | [Amend] Filing |
| Sep 18, 2026 | 4 | Filing |
| Sep 18, 2026 | 8-K | Current Report |
| Sep 18, 2026 | 424B5 | Filing |
| Aug 21, 2026 | EFFECT | Filing |
| Aug 21, 2026 | 424B5 | Filing |
| Aug 18, 2026 | 8-K | Current Report |
CapsoVision Inc.
| Country | United States |
| IPO Date | Jul 2, 2025 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 99 |
| CEO | Kang-Huai Wang |
Contact Details
18805 Cox Avenue Saratoga,
California 95070 United States
Stock Details
| Ticker Symbol | CV |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001378325 |
| CUSIP Number | 140935107 |
| ISIN Number | US1409351079 |
| SIC Code | 3845 |
Add to Watchlist
Select watchlists to add or remove CV